A detailed history of Adviser Investments LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Adviser Investments LLC holds 61,036 shares of NVO stock, worth $6.59 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
61,036
Previous 83,573 26.97%
Holding current value
$6.59 Million
Previous $11.9 Million 39.08%
% of portfolio
0.09%
Previous 0.16%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$119.07 - $145.42 $2.68 Million - $3.28 Million
-22,537 Reduced 26.97%
61,036 $7.27 Million
Q2 2024

Aug 12, 2024

SELL
$122.71 - $146.91 $532,561 - $637,589
-4,340 Reduced 4.94%
83,573 $11.9 Million
Q1 2024

Apr 29, 2024

SELL
$102.11 - $135.92 $499,624 - $665,056
-4,893 Reduced 5.27%
87,913 $11.3 Million
Q4 2023

Feb 01, 2024

BUY
$87.78 - $105.45 $6.4 Million - $7.69 Million
72,924 Added 366.78%
92,806 $9.6 Million
Q3 2023

Oct 11, 2023

BUY
$90.94 - $199.54 $1.81 Million - $3.97 Million
19,882 New
19,882 $1.81 Million
Q2 2022

Jul 14, 2022

SELL
$103.24 - $121.81 $13,008 - $15,348
-126 Reduced 1.28%
9,734 $1.09 Million
Q4 2021

Jan 31, 2022

SELL
$95.88 - $117.08 $59,637 - $72,823
-622 Reduced 5.93%
9,860 $1.1 Million
Q3 2021

Nov 05, 2021

SELL
$84.42 - $106.62 $43,391 - $54,802
-514 Reduced 4.67%
10,482 $1.01 Million
Q2 2021

Jul 09, 2021

SELL
$67.66 - $84.76 $5,818 - $7,289
-86 Reduced 0.78%
10,996 $921,000
Q1 2021

May 05, 2021

BUY
$67.06 - $75.82 $14,216 - $16,073
212 Added 1.95%
11,082 $747,000
Q4 2020

Jan 26, 2021

BUY
$63.89 - $73.8 $39,739 - $45,903
622 Added 6.07%
10,870 $759,000
Q3 2020

Nov 13, 2020

BUY
$63.69 - $70.22 $891 - $983
14 Added 0.14%
10,248 $711,000
Q1 2020

Apr 08, 2020

SELL
$49.46 - $64.78 $24,730 - $32,390
-500 Reduced 4.66%
10,234 $616,000
Q4 2019

Feb 07, 2020

BUY
$49.86 - $58.26 $24,930 - $29,130
500 Added 4.89%
10,734 $621,000
Q3 2019

Nov 13, 2019

SELL
$47.54 - $53.43 $23,770 - $26,715
-500 Reduced 4.66%
10,234 $529,000
Q4 2018

Jan 25, 2019

SELL
$41.54 - $47.25 $11,423 - $12,993
-275 Reduced 2.5%
10,734 $494,000
Q1 2018

May 14, 2018

SELL
$48.49 - $58.14 $14,547 - $17,442
-300 Reduced 2.65%
11,009 $542,000
Q4 2017

Feb 12, 2018

BUY
$47.53 - $53.73 $23,765 - $26,865
500 Added 4.63%
11,309 $607,000
Q3 2017

Oct 23, 2017

BUY
$41.15 - $49.22 $444,790 - $532,018
10,809
10,809 $520,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $244B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Adviser Investments LLC Portfolio

Follow Adviser Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adviser Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adviser Investments LLC with notifications on news.